Systemic Immune Remodeling in Breast Cancer: Selective Enrichment of TNFR2+ Circulating Lymphocytes in Breast Cancer
Elevated TNFR2 expression on peripheral lymphocytes, despite overall lymphocyte depletion, underscores its potential as a biomarker and immunomodulatory target in breast cancer progression.
Authors
- Hosein Hakimi
- Fereshteh Mehdipour (ORCID: https://orcid.org/0000-0002-2888-0930)
- Farnaz Sedghy
- Faezeh Absalan (ORCID: https://orcid.org/0009-0008-0702-9566)
- Mahmood Shariat
- Abbas Ghaderi
- Reza Azizi
Institutions
- Shiraz University of Medical Sciences (IR)
- Kerman University of Medical Sciences (IR)
Publication Details
- Journal
- Breast Cancer Targets and Therapy
- Published
- 2026-02-01
- DOI
- https://doi.org/10.2147/bctt.s563472
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00